[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.154.210. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Other Articles
December 16, 1950

THERAPEUTIC EFFECT OF PITUITARY ADRENOCORTICOTROPIC HORMONE (ACTH) IN A CASE OF HENOCH-SCHÖNLEIN VASCULAR (ANAPHYLACTOID) PURPURA

Author Affiliations

Boston

From the Ziskind Laboratories (Hematology Section) of the Joseph H. Pratt and New England Center Hospitals, the Boston Floating Hospital and the Departments of Medicine and Pediatrics, Tufts College Medical School.

JAMA. 1950;144(16):1372-1374. doi:10.1001/jama.1950.62920160004010a
Abstract

Increasing attention has recently been focused on a group of conditions characterized by a widespread alteration of the collagenous tissue. Active vasculitis of various regions appears to be, among other characteristics, a fairly constant common denominator in this group of diseases which includes such heterogeneous conditions as disseminated lupus erythematosus, acute glomerulonephritis, polyarteritis nodosa and serum sickness. Some of these conditions have a possible allergic causation, while in others the pathogenetic mechanism is obscure. Recently an additional characteristic has come to the fore, i. e., a variably favorable response to treatment with anterior pituitary adrenocorticotropic hormone (ACTH).1

The nonthrombopenic Henoch-Schönlein type of vascular or anaphylactoid purpura is another condition which may be related to this group in view of its possible allergic basis and its severe generalized vasculities. The classic capillary lesions are represented by active inflammatory changes centered around the smallest vessels with infiltration of inflammatory cells, and

First Page Preview View Large
First page PDF preview
First page PDF preview
×